December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together experts in dry eye disease (DED). In this educational program, these experts share insights into recent neuromodulation opportunities in DED, as well as emerging mechanisms of action, such as targeting TRPM8 thermoreceptors to...
Free CE/CME
December 14, 2025
July 14, 2026
Cardiometabolic disorders are a significant source of morbidity and mortality in psoriatic disease. The presence of traditional cardiovascular (CV) risk factors, such as hypercholesterolemia, metabolic syndrome, and obesity, contributes to the elevated risk of CV disease in patients with psoriasis....
Free CE/CME
December 14, 2025
July 14, 2026
Macular telangiectasia type 2 (MacTel) is a rare, progressive retinal disease characterized by neurodegenerative changes, localized retinal degeneration, and alterations in the retinal vasculature. It usually presents bilaterally and leads to gradual central vision loss, and its early signs and...
Free CE/CME
December 14, 2025
July 14, 2026
Heart failure (HF), a major challenge in cardiovascular medicine, presents significant morbidity and mortality despite advances in treatment. Mineralocorticoid receptor antagonists (MRAs) have emerged as a cornerstone of therapy, demonstrating substantial benefits in reducing hospitalization, improving survival, and enhancing quality...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in treating major depressive disorder (MDD). In this educational program, these experts discuss managing patients with MDD by reviewing patient scenarios, reflecting on how to handle challenging cases, and integrating relevant...
Free CE/CME
December 14, 2025
July 14, 2026
Vascular endothelial growth factor (VEGF) is essential in the pathogenesis of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). As such, VEGF inhibitors have become commonly used and effective pharmacologic strategies for both diseases. However, limitations exist, such...
Free CE/CME
December 14, 2025
July 14, 2026
X-linked retinitis pigmentosa (XLRP), which commonly results from mutations in the RPGR gene or the RP2 gene, is frequently more severe than other forms of retinitis pigmentosa. The onset of legal blindness occurs decades earlier in male patients than in...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in the field of schizophrenia. In this educational program, these experts discuss the rationale for muscarinic receptor modulation, clinical data, and the use of xanomeline/trospium chloride, the recently approved therapy in...
Free CE/CME
December 14, 2025
July 14, 2026
This online, on-demand virtual symposium brings together renowned experts in paroxysmal nocturnal hemoglobinuria (PNH). In this educational program, these experts engage in an in-depth exploration of PNH, with a focus on pathophysiology and disease burden, clinical manifestations, best practices for...
Free CE/CME
December 14, 2025
July 14, 2026
The underlying pathophysiology of pulmonary arterial hypertension (PAH), a variant of pulmonary hypertension, originates in the pulmonary vasculature. Due to the rarity of PAH, few pediatric patients receive specialized therapy. In this video-based program, a pediatric pulmonologist and a pediatric...
Free CE/CME